AbbVie Inc. (ABBV)
AbbVie Inc is an American multinational biopharmaceutical company based in North Chicago, Illinois. It was created in 2013 as a spin-off of Abbott Laboratories. AbbVie is focused on developing and marketing advanced therapies for severe and chronic conditions, emphasizing oncology, immunology, and virology.
Company Info
US00287Y1091
00287Y109
Jan 2, 2013
Highlights
$296.46B
$2.87
58.45
0.40
$55.53B
$42.72B
$25.57B
$132.79 - $207.32
$204.74
1.03%
3.61
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in AbbVie Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
AbbVie Inc. had a return of 12.22% year-to-date (YTD) and 25.35% in the last 12 months. Over the past 10 years, AbbVie Inc. had an annualized return of 14.21%, outperforming the S&P 500 benchmark which had an annualized return of 11.13%.
ABBV
12.22%
-10.07%
6.93%
25.35%
19.36%
14.21%
^GSPC (Benchmark)
24.05%
1.08%
11.50%
30.38%
13.77%
11.13%
Monthly Returns
The table below presents the monthly returns of ABBV, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 7.10% | 7.09% | 3.44% | -9.85% | -0.86% | 6.38% | 9.04% | 5.93% | 0.60% | 4.07% | 12.22% | ||
| 2023 | -7.71% | 4.16% | 3.55% | -4.30% | -8.71% | -2.34% | 12.25% | -1.75% | 1.43% | -4.34% | 0.86% | 8.83% | -0.23% |
| 2022 | 2.15% | 7.95% | 9.70% | -8.62% | 0.33% | 3.93% | -5.42% | -6.31% | -0.19% | 10.19% | 10.10% | 0.27% | 24.01% |
| 2021 | -3.24% | 5.13% | 0.45% | 4.28% | 1.52% | -0.49% | 4.40% | 3.85% | -10.69% | 7.59% | 0.53% | 17.45% | 32.43% |
| 2020 | -7.26% | 5.79% | -11.11% | 9.50% | 12.74% | 5.95% | -2.15% | 0.91% | -8.54% | -1.52% | 22.89% | 2.46% | 27.72% |
| 2019 | -11.84% | -1.31% | 1.70% | -0.18% | -3.38% | -5.20% | -6.99% | -1.32% | 15.18% | 6.59% | 10.28% | 0.92% | 1.47% |
| 2018 | 16.87% | 3.22% | -18.29% | 3.06% | 2.48% | -6.36% | 0.56% | 4.07% | -1.46% | -16.81% | 21.09% | -2.21% | -0.96% |
| 2017 | -1.43% | 1.19% | 5.37% | 2.20% | 0.12% | 9.83% | -2.72% | 7.71% | 18.01% | 2.27% | 7.39% | -0.22% | 60.07% |
| 2016 | -6.35% | -0.53% | 4.60% | 7.82% | 3.16% | -1.62% | 7.92% | -3.22% | -1.61% | -10.74% | 9.00% | 2.99% | 9.79% |
| 2015 | -7.09% | 0.25% | -3.24% | 11.37% | 2.98% | 0.90% | 4.97% | -10.86% | -12.82% | 10.46% | -2.35% | 1.87% | -6.50% |
| 2014 | -6.04% | 3.41% | 0.96% | 2.23% | 4.32% | 3.88% | -6.56% | 5.62% | 4.49% | 10.69% | 9.05% | -5.43% | 27.92% |
| 2013 | 5.71% | 0.63% | 10.46% | 13.97% | -7.30% | -3.16% | 11.03% | -6.31% | 4.98% | 9.29% | 0.00% | 9.00% | 56.38% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ABBV is 74, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for AbbVie Inc. (ABBV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
AbbVie Inc. provided a 3.70% dividend yield over the last twelve months, with an annual payout of $6.20 per share. The company has been increasing its dividends for 10 consecutive years.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $6.20 | $5.92 | $5.64 | $5.20 | $4.72 | $4.28 | $3.59 | $2.56 | $2.28 | $2.02 | $1.66 | $1.60 |
Dividend yield | 3.70% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% | 3.03% |
Monthly Dividends
The table displays the monthly dividend distributions for AbbVie Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $1.55 | $0.00 | $0.00 | $1.55 | $0.00 | $0.00 | $1.55 | $0.00 | $0.00 | $1.55 | $0.00 | $6.20 | |
| 2023 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $5.92 |
| 2022 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 | $5.64 |
| 2021 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 | $5.20 |
| 2020 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 | $4.72 |
| 2019 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 | $4.28 |
| 2018 | $0.71 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 | $3.59 |
| 2017 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $2.56 |
| 2016 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $2.28 |
| 2015 | $0.49 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $2.02 |
| 2014 | $0.40 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $1.66 |
| 2013 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $1.60 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the AbbVie Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AbbVie Inc. was 45.09%, occurring on Aug 15, 2019. Recovery took 330 trading sessions.
The current AbbVie Inc. drawdown is 17.71%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -45.09% | Jan 29, 2018 | 390 | Aug 15, 2019 | 330 | Dec 4, 2020 | 720 |
| -31.61% | Jul 29, 2015 | 61 | Oct 22, 2015 | 383 | May 2, 2017 | 444 |
| -21.92% | Apr 11, 2022 | 120 | Sep 30, 2022 | 320 | Jan 10, 2024 | 440 |
| -19.82% | Dec 8, 2014 | 43 | Feb 9, 2015 | 90 | Jun 18, 2015 | 133 |
| -19.07% | Nov 1, 2024 | 11 | Nov 15, 2024 | — | — | — |
Volatility
Volatility Chart
The current AbbVie Inc. volatility is 15.61%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of AbbVie Inc. compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for ABBV in comparison to other companies of the Drug Manufacturers - General industry. Currently, ABBV has a PE value of 58.5. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for ABBV in comparison to other companies of the Drug Manufacturers - General industry. Currently, ABBV has a PEG value of 0.4. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for AbbVie Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |